Sara-Beth Sutherland
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Genetics top 5%
- Genetic Associations and Epidemiology
Papers in
-
- Acute Kidney Injury Research 5
-
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 1
- Journals
- JAMA (5 papers)Nature (4 papers)Critical Care (2 papers)Intensive Care Medicine (2 papers)JAMA Network Open (1 paper)
- Partner nations
- CanadaUnited Kingdom
In The Last Decade
Sara-Beth Sutherland
14 papers receiving 1.5k citations
Sara-Beth Sutherland's Hit Papers
Peers
Comparison fields: 5 of 79
- Infectious Diseases 799
- Genetics 504
- Nephrology 69
- Neurology 87
- Internal Medicine 18
Countries citing papers authored by Sara-Beth Sutherland
This map shows the geographic impact of Sara-Beth Sutherland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara-Beth Sutherland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara-Beth Sutherland more than expected).
Fields of papers citing papers by Sara-Beth Sutherland
This network shows the impact of papers produced by Sara-Beth Sutherland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara-Beth Sutherland. The network helps show where Sara-Beth Sutherland may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Mapping the human genetic architecture of COVID-19 Hit paper breakdown → | 2021 | 656 |
| 2 | Whole-genome sequencing reveals host factors underlying critical COVID-19 Hit paper breakdown → | 2022 | 233 |
| 3 | 2021 | 166 | |
| 4 | GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 Hit paper breakdown → | 2023 | 125 |
| 5 | 2022 | 105 | |
| 6 | 2022 | 100 | |
| 7 | 2023 | 60 | |
| 8 | 2023 | 46 | |
| 9 | 2023 | 41 | |
| 10 | 2023 | 34 | |
| 11 | 2022 | 15 | |
| 12 | 2022 | 13 | |
| 13 | 2024 | 8 | |
| 14 | 2025 | 1 | |
| 15 | 2021 | 0 | |
| 16 | 2025 | 0 |
About Sara-Beth Sutherland
Sara-Beth Sutherland is a scholar working on Nephrology, Infectious Diseases, Genetics, Nutrition and Dietetics and Economics and Econometrics, having authored 16 papers that have together received 1.6k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Genetic Associations and Epidemiology (6 papers), Acute Kidney Injury Research (5 papers), Health Systems, Economic Evaluations, Quality of Life (1 paper), Vitamin C and Antioxidants Research (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). The work is most often cited by research in Infectious Diseases (799 citations), Genetics (504 citations), Nephrology (69 citations), Neurology (87 citations) and Internal Medicine (18 citations). Sara-Beth Sutherland has collaborated with scholars based in Canada and United Kingdom. Their work appears in journals such as JAMA, Nature, Critical Care, Intensive Care Medicine and JAMA Network Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.